AstraZeneca vaccine (Photo: Zeljko Lukunic/PIXSELL) AstraZeneca vaccine (Photo: Zeljko Lukunic/PIXSELL)

The European Union's dispute with vaccine producer AstraZeneca continues, with Brussels restricting pharmaceutical companies from exporting vaccines until they have honored the contracts they have with the EU. The EU had approved restrictions on the export of COVID-19 vaccines back in January, with the agreement that they would only be applied if a pharmaceutical company fails to honor the obligations outlined in its contract with the EU regarding the delivery of the vaccine. The restriction however, are set to expire at the end of March.

"This is not about banning vaccine exports, this is about making sure that companies deliver on their commitment to the member states and the European Union that are inscribed in contracts that they have with us. Therefore this is the objective, to make sure that the contracts that we have signed are respected, and in that context, the president has said that of course we see that actually companies that manufacture doses in the EU have been exporting very widely, which is in itself a good thing, but that we want to see reciprocity and proportionality in these exports. And this our position,” said European Commission Spokesman Eric Mamer.

Mamer added that the commission wants to avoid any future concerns that could threaten vaccination goals: “Quite frankly, this is about making sure that member states have the vaccines they need to ensure the roll-out of their vaccination strategies, and quite clearly as we have seen and said, we are expecting an increase of delivery of vaccines over the coming month, in order to be able to speed up the vaccination effort."

Source: HRT